Redline Pharmacy Solutions

FDA Regulatory Profile

Redline Pharmacy Solutions appears in FDA public data with 6 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1009-2020, Class II) was initiated on February 24, 2020.

Summary

Total Recalls
6
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1009-2020Class IIErtapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100February 24, 2020
D-1007-2020Class IIMorphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 OsborneFebruary 24, 2020
D-1008-2020Class IIDaptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #February 24, 2020
D-1011-2020Class IIMorphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 February 24, 2020
D-1006-2020Class IIAcetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline Specialty Pharmacy,February 24, 2020
D-1010-2020Class IIVancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #February 24, 2020